Index of /content/lionbridge/it/case-study

[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory   -  
[DIR]3play-media-case-stu..>2024-07-15 10:50 -  
[TXT]3q-digital-case-stud..>2024-07-16 07:57 106K 
[TXT]3q-digital-case-stud..>2024-07-16 07:57 68  
[DIR]3q-digital-case-stud..>2024-07-15 11:57 -  
[TXT]a-global-web-publish..>2024-07-18 08:41 100K 
[TXT]a-global-web-publish..>2024-07-18 08:41 68  
[DIR]a-global-web-publish..>2024-07-16 01:07 -  
[TXT]ai-content-optimizat..>2024-07-18 18:15 100K 
[TXT]ai-content-optimizat..>2024-07-18 18:15 68  
[DIR]ai-content-optimizat..>2024-07-16 01:06 -  
[TXT]amazon-web-services-..>2024-07-17 15:10 99K 
[TXT]amazon-web-services-..>2024-07-17 15:10 68  
[DIR]amazon-web-services-..>2024-07-16 10:12 -  
[TXT]an-efficient-agile-p..>2024-07-18 20:46 103K 
[TXT]an-efficient-agile-p..>2024-07-18 20:46 68  
[DIR]an-efficient-agile-p..>2024-07-17 02:32 -  
[DIR]an-online-glossary-f..>2024-07-15 09:53 -  
[TXT]biomarin-case-study...>2024-07-18 21:07 91K 
[TXT]biomarin-case-study...>2024-07-18 21:07 68  
[DIR]biomarin-case-study/ 2024-07-15 12:19 -  
[TXT]biopharmaceutical-cl..>2024-07-18 18:03 91K 
[TXT]biopharmaceutical-cl..>2024-07-18 18:03 68  
[DIR]biopharmaceutical-cl..>2024-07-16 09:56 -  
[TXT]canon-case-study.html 2024-07-18 10:50 96K 
[TXT]canon-case-study.html.h2024-07-18 10:50 68  
[DIR]canon-case-study/ 2024-07-15 10:33 -  
[TXT]clincierge-case-stud..>2024-07-15 23:46 96K 
[TXT]clincierge-case-stud..>2024-07-15 23:46 68  
[DIR]clincierge-case-study/ 2024-07-16 00:58 -  
[TXT]clinical-labeling-ca..>2024-07-18 17:11 90K 
[TXT]clinical-labeling-ca..>2024-07-18 17:11 68  
[TXT]coa-case-study.html 2024-07-15 12:51 98K 
[TXT]coa-case-study.html.h 2024-07-15 12:51 68  
[DIR]coa-case-study/ 2024-07-15 12:51 -  
[TXT]culturally-relevant-..>2024-07-17 22:27 104K 
[TXT]culturally-relevant-..>2024-07-17 22:27 68  
[TXT]danish-hemophilia-so..>2024-07-18 04:40 93K 
[TXT]danish-hemophilia-so..>2024-07-18 04:40 68  
[DIR]danish-hemophilia-so..>2024-07-16 10:01 -  
[TXT]dorel-juvenile-case-..>2024-07-15 23:08 104K 
[TXT]dorel-juvenile-case-..>2024-07-15 23:08 68  
[DIR]dorel-juvenile-case-..>2024-07-15 12:56 -  
[TXT]ecoa-providers-case-..>2024-07-18 15:09 92K 
[TXT]ecoa-providers-case-..>2024-07-18 15:09 68  
[TXT]epson-europe-case-st..>2024-07-16 00:33 107K 
[TXT]epson-europe-case-st..>2024-07-16 00:33 68  
[TXT]fast-agile-publishin..>2024-07-18 20:53 88K 
[TXT]fast-agile-publishin..>2024-07-18 20:53 68  
[TXT]fliplingo-case-study..>2024-07-15 15:58 105K 
[TXT]fliplingo-case-study..>2024-07-15 15:58 68  
[DIR]fliplingo-case-study..>2024-07-16 01:16 -  
[TXT]gengo-case-study.html 2024-07-18 13:02 91K 
[TXT]gengo-case-study.html.h2024-07-18 13:02 68  
[DIR]gengo-case-study/ 2024-07-15 12:09 -  
[TXT]global-biopharma-com..>2024-07-15 18:51 98K 
[TXT]global-biopharma-com..>2024-07-15 18:51 68  
[DIR]global-biopharma-com..>2024-07-15 09:31 -  
[TXT]how-ai-enables-authe..>2024-07-18 21:17 91K 
[TXT]how-ai-enables-authe..>2024-07-18 21:17 68  
[TXT]how-bae-systems-bene..>2024-07-18 21:20 94K 
[TXT]how-bae-systems-bene..>2024-07-18 21:20 68  
[TXT]how-lionbridge-helpe..>2024-07-15 23:51 102K 
[TXT]how-lionbridge-helpe..>2024-07-15 23:51 68  
[DIR]how-lionbridge-helpe..>2024-07-16 10:17 -  
[TXT]how-lionbridge-helpe..>2024-07-15 23:51 114K 
[TXT]how-lionbridge-helpe..>2024-07-15 23:51 68  
[TXT]how-lionbridge-impro..>2024-07-17 20:29 95K 
[TXT]how-lionbridge-impro..>2024-07-17 20:29 68  
[TXT]how-lionbridge-partn..>2024-07-18 20:16 105K 
[TXT]how-lionbridge-partn..>2024-07-18 20:16 68  
[TXT]how-lionbridges-tech..>2024-07-18 11:32 95K 
[TXT]how-lionbridges-tech..>2024-07-18 11:32 68  
[DIR]how-lionbridges-tech..>2024-07-15 11:03 -  
[TXT]japan-intercultural-..>2024-07-16 01:05 108K 
[TXT]japan-intercultural-..>2024-07-16 01:05 68  
[DIR]japan-intercultural-..>2024-07-16 01:30 -  
[TXT]kuoni-case-study-how..>2024-07-15 23:15 111K 
[TXT]kuoni-case-study-how..>2024-07-15 23:15 68  
[DIR]kuoni-case-study-how..>2024-07-15 11:42 -  
[TXT]le-monde-case-study-..>2024-07-18 21:50 98K 
[TXT]le-monde-case-study-..>2024-07-18 21:50 68  
[DIR]le-monde-case-study-..>2024-07-15 10:09 -  
[TXT]lionbridge-ai-conten..>2024-07-17 23:08 96K 
[TXT]lionbridge-ai-conten..>2024-07-17 23:08 68  
[DIR]lionbridge-ai-conten..>2024-07-15 12:25 -  
[TXT]lionbridge-helps-glo..>2024-07-18 16:19 84K 
[TXT]lionbridge-helps-glo..>2024-07-18 16:19 68  
[DIR]lionbridge-helps-glo..>2024-07-16 00:29 -  
[TXT]lionbridge-opi-disas..>2024-07-18 18:36 83K 
[TXT]lionbridge-opi-disas..>2024-07-18 18:36 68  
[TXT]mirka-case-study.html 2024-07-16 05:57 99K 
[TXT]mirka-case-study.html.h2024-07-16 05:57 68  
[DIR]mirka-case-study/ 2024-07-18 16:28 -  
[TXT]multilingual-marketi..>2024-07-18 17:54 91K 
[TXT]multilingual-marketi..>2024-07-18 17:54 68  
[DIR]multilingual-marketi..>2024-07-15 10:49 -  
[TXT]prisma-international..>2024-07-18 20:28 98K 
[TXT]prisma-international..>2024-07-18 20:28 68  
[TXT]sap-translation-case..>2024-07-15 12:51 107K 
[TXT]sap-translation-case..>2024-07-15 12:51 68  
[DIR]sap-translation-case..>2024-07-15 12:51 -  
[TXT]sustainability-case-..>2024-07-18 16:19 106K 
[TXT]sustainability-case-..>2024-07-18 16:19 68  
[TXT]swisscom-annual-repo..>2024-07-18 11:32 93K 
[TXT]swisscom-annual-repo..>2024-07-18 11:32 68  
[DIR]swisscom-annual-repo..>2024-07-16 01:16 -  
[TXT]swisscom-case-study-..>2024-07-18 21:20 94K 
[TXT]swisscom-case-study-..>2024-07-18 21:20 68  
[TXT]telecommunications-o..>2024-07-18 18:14 91K 
[TXT]telecommunications-o..>2024-07-18 18:14 68  
[DIR]telecommunications-o..>2024-07-15 11:29 -  
[TXT]the-swiss-economic-f..>2024-07-18 21:41 92K 
[TXT]the-swiss-economic-f..>2024-07-18 21:41 68  
[DIR]the-swiss-economic-f..>2024-07-15 12:50 -  
[TXT]translations-for-glo..>2024-07-15 15:59 93K 
[TXT]translations-for-glo..>2024-07-15 15:59 68  
[TXT]vaneck-case-study-ho..>2024-07-18 11:32 99K 
[TXT]vaneck-case-study-ho..>2024-07-18 11:32 68  
[DIR]vaneck-case-study-ho..>2024-07-15 11:47 -  
[TXT]vestiaire-collective..>2024-07-15 23:10 108K 
[TXT]vestiaire-collective..>2024-07-15 23:10 68